Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank64
3Y CAGR-34.7%
5Y CAGR-25.6%
Studio
Year-over-Year Change

Year-over-year net income growth rate

3Y CAGR
-34.7%/yr
Annual compound
5Y CAGR
-25.6%/yr
Recent deceleration
Percentile
P64
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202530.78%
2024129.50%
2023-14.05%
2022110.42%
2021-47.35%
2020135.24%
2019193.74%
2018-84.68%
2017-1.88%
201610.68%